Cargando…

Pharmaceutical regulations in India: the missing links

Detalles Bibliográficos
Autor principal:	Narayanan, Lalitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467553/ http://dx.doi.org/10.1186/1753-6561-6-S5-P9

Ejemplares similares

Primary ciliary dyskinesia and humoral immunodeficiency - what is the missing link?
por: Boon, Mieke, et al.
Publicado: (2013)

Imputing missing genotypes: effects of methods and patterns of missing data
por: Ogut, Funda, et al.
Publicado: (2011)

Predominance of HBV genotype D in southern part of India
por: Narayanan, Kalyanaraman, et al.
Publicado: (2014)

P08 The missing links in the chain
por: Bouraoui, Aicha, et al.
Publicado: (2021)

Pharmaceutical distribution remuneration in Europe
por: Vogler, Sabine, et al.
Publicado: (2015)

Strengthening training and supervisory systems to improve Skilled Birth Assistance in Jharkhand, India
por: Pasricha, Ragini, et al.
Publicado: (2012)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Decentralizing treatment services with link ART centres- experience from Karnataka, South India
por: Fahim, Salma, et al.
Publicado: (2012)

Performance of community health insurance in India: findings from empirical studies
por: Devadasan, Narayanan, et al.
Publicado: (2012)

Breast cancers missed by the arbitration process
por: Lee, CM, et al.
Publicado: (2009)

Missed fractures in severely injured patients
por: Park, H
Publicado: (2015)

Morinda citrifolia and the pharmaceutical industry: technological prospecting and potential
por: Oliveira, Clauberto, et al.
Publicado: (2014)

Assessment of human resources capacity of pharmaceutical warehouses in Cameroon
por: Ayuk, Samuel Ottu, et al.
Publicado: (2014)

Arthritis in Down's syndrome is still being missed
por: Cruikshank, M, et al.
Publicado: (2008)

PA02.03. Pharmaceutical standardization of Ropya raj rasa
por: Agrawal, Sachin, et al.
Publicado: (2013)

An empirical evaluation of the impact of missing data on treatment effect
por: Joseph, Royes, et al.
Publicado: (2015)

Reported reasons for missing data and the interplay with trial setting
por: Kearney, Anna, et al.
Publicado: (2015)

Spotting senile systemic amyloidosis: why we miss it
por: Fontana, Marianna, et al.
Publicado: (2015)

Analysis of physiological functions of different human serum albumin pharmaceutical preparations
por: Di Giambattista, M, et al.
Publicado: (2007)

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
por: Docteur, Elizabeth, et al.
Publicado: (2015)

‘She was referred from one hospital to another’: evidence on emergency obstetric care in Karnataka, India
por: Vijayashree, HY, et al.
Publicado: (2012)

Simulation study - handling missing covariates in the context of external validation
por: Bonnett, Laura J, et al.
Publicado: (2011)

AMD Genetics in India: The Missing Links
por: Anand, Akshay, et al.
Publicado: (2016)

Missed opportunities to facilitate the diagnosis of colon cancer in emergency department patients
por: Delaney, K
Publicado: (2008)

Challenges of implementing multiple imputation to address missing data in economic evaluations
por: Fernandez, Aida Moure, et al.
Publicado: (2015)

Identification of a novel imprinting mechanism at the X-linked imprinted locus, X-linked Lymphocyte Regulated 3/4 (Xlr3/4)
por: Qureshi, Sohaib M, et al.
Publicado: (2013)

Impact before and after introduction of a multifaceted quality improvement intervention on device-related infections in a pediatric ICU in India: a single-centre experience
por: Rameshkumar, R, et al.
Publicado: (2014)

Effectiveness of pharmaceutical strategies for pandemic H1N1 2009 influenza in TAIWAN
por: Wu, U-I, et al.
Publicado: (2011)

Pragmatic approaches to mitigating missing data and research priorities to assess the effectiveness of interventions
por: Kearney, Anna, et al.
Publicado: (2015)

Metabolomics data analysis and missing value issues with application to infarcted mouse hearts
por: Shah, Jasmit S, et al.
Publicado: (2015)

Adjusting for informative missing outcome data in clinical trials with longitudinal study designs
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2013)

Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets
por: Hristova, Kristina, et al.
Publicado: (2015)

A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden
por: Brännström, J, et al.
Publicado: (2010)

Chronic recurrent multifocal osteomyelitis: follow up Longitudinal case series study for five years with radiographic and scintigraphic imaging perspective and health outcome analysis with EQ5D-5L
por: Roy, N, et al.
Publicado: (2015)

PA02.02. A comprehensive review of “Vaidya Vinoda” manuscript with reference to formulations and pharmaceutical procedures
por: Vyas, Ramakant
Publicado: (2013)

PA02.05. Pharmaceutical and analytical evaluation of Lasuna Kshirpaka w.s.r to charaka and sharangadhara methods.
por: Suryawanshi, Nilesh
Publicado: (2013)

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
por: Hall, Peter, et al.
Publicado: (2015)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Bias of complete-case analysis of williams square crossover designs when data are missing not at random
por: Bazakou, Sofia, et al.
Publicado: (2015)

The use of multiple imputation (MI) in cluster randomised trials with suspected missing not at random (MNAR) outcome
por: Playle, Rebecca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kf46djcmbbagjf3q887scv9qtq